会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • APOPTOSIS-INDUCING COMPOUNDS
    • 杀虫剂诱导化合物
    • WO0158904A9
    • 2002-02-21
    • PCT/IE0100020
    • 2001-02-09
    • TRINITY COLLEGE DUBLINUNI DI SIENAWILLIAMS DAVID CLIVEZISTERER DANIELA MNACCI VITOCAMPIANI GIUSEPPE
    • WILLIAMS DAVID CLIVEZISTERER DANIELA MNACCI VITOCAMPIANI GIUSEPPE
    • A61P35/00C07D498/04C07D498/14C07D513/04A61K31/554
    • C07D513/04
    • The invention relates to a pharmaceutical composition comprising an apoptosis-inducing amount of a compound having general formula (I), wherein: (i) R1 represents an unsubstituted C6 or C10 aryl group; or a C6 aryl group substituted with Me or OMe; (ii) A represents O, S or S partially oxidized to sulfoxide; (iii) the cyclic group labelled F represents an unsubstituted C6 or C10 aryl-fused group or a C5 heteroaryl-fused group (nitrogen as heteroatom) or a benzo-fused system substituted with ethoxycarbonyl function; (iv) and Y represents the group (A) wherein R2 and R3 are independently hydrogen; or methyl; or Y represents the group CH3 or a (CH2)2CH3 group; or an unsubstituted C5 heteroaryl group (nitrogen as heteroatom). The compositions may be used for the treatment of tumours or other cancerous conditions, such as CML (chronic myeloid leukaemia), AML, in AIDS-related lymphomas (such as Karpowski's sarcoma, a sub-cutaneous lymphoma) and used as apoptotic agents in the treatment of cancers generally.
    • 本发明涉及包含细胞凋亡诱导剂量的具有通式(I)的化合物的药物组合物,其中:(i)R 1表示未取代的C 6或C 10芳基; 或被Me或OMe取代的C6芳基; (ii)A表示O,S或S部分氧化成亚砜; (iii)标记为F的环状基团表示未取代的C6或C10芳基稠合基团或C5杂芳基稠合基团(氮作为杂原子)或被乙氧基羰基官能团取代的苯并稠合体系; (ⅳ),Y表示其中R2和R3独立地为氢的基团(A); 或甲基; 或Y表示基团CH 3或(CH 2)2 CH 3基团; 或未取代的C5杂芳基(氮作为杂原子)。 组合物可用于治疗肿瘤或其它癌症病症,例如艾滋病相关淋巴瘤(如卡尔波夫斯基氏肉瘤,亚皮肤淋巴瘤)中的CML(慢性骨髓性白血病),AML,并用作细胞凋亡剂 一般治疗癌症。